| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| Notice of Effectiveness |
| Effectiveness Date: |
January 27,
2026 |
| Accession Number: |
0001140361-26-002205 |
| Submission Type: |
POS AM |
| CIK: |
0001454789 |
| Company Name: |
Astria Therapeutics, Inc. |
| File Number: |
333-254174 |
|
